Cargando…
Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
Most studies suggest that obsessive-compulsive disorder runs a chronic course. Only 40%–70% of patients respond to first-line treatment with selective serotonin reuptake inhibitors (SSRIs). The most common pharmacological strategy used in clinical practice for partial responders to SSRIs is augmenta...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343405/ https://www.ncbi.nlm.nih.gov/pubmed/30745677 http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_519_18 |